Increased arterial stiffness in children treated with anthracyclines for malignant disease;Povećana krutost arterija u djece liječene antraciklinima zbog maligne bolesti

Collegium Antropologicum

Volumn 35, Issue 2, 2011, Pages 389-395

  Herceg Čavrak, Vesna ^a   Ahel, Vladimir ^b   Batinica, Maja ^a   Matec, Lana ^a   Kardoš, Danijel ^c  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c Valpovo Health Center   (Croatia)

Author keywords

Anthracyclines; Arteries; Child; Drug effects; Drug therapy; Neoplasms; Oscillometry

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; FEMALE; HUMAN; MALE; NEOPLASM; PATHOPHYSIOLOGY;

ADOLESCENT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; NEOPLASMS; YOUNG ADULT;

EID: 79959759522     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. OEFFINGER KC, HUDSON MM, CA Cancer J Clin, 54 (2004) 208.
2. YEH ET, TONG AT, LENIHAN DJ, YUSUF SW, SWAFFORD J, CHAMPION C, DURAND JB, GIBBS H, ZAFARMAND AA, EWER MS, Circulation, 109 (2004) 109.
3. GIANNI L, HERMAN EH, LIPSHULTZ SE, MINOTTI G, SARVAZYAN N, SAWYER DB, J Clin Oncol, 26 (2008) 3777.
4. JEMAL A, SIEGEL R, XU J, WARD E, CA Cancer J Clin, 60 (2010) 277.
5. LIPSHULTZ SE, ADAMS MJ, J Clin Oncol, 28 (2010) 1276.
6. MERTENS AC, YASUI Y, NEGLIA JP, POTTER JD, NESBIT ME, JR., RUCCIONE K, SMITHSON WA, ROBISON LL, J Clin Oncol, 19 (2001) 3163.
7. SAWYER DB, PENG X, CHEN B, PENTASSUGLIA L, LIM CC, Prog Cardiovasc Dis, 53 (2010) 105.
8. COHN JN, Circulation, 113 (2006) 601.
9. MITCHELL GF, Artery Res, 3 (2009) 56.
10. ARNETT DK, GLASSER SP, MCVEIGH G, PRINEAS R, FINKLESTEIN S, DONAHUE R, COHN JN, SINAIKO A, Am J Hypertens, 14 (2001) 200.
11. DERNELLIS J, PANARETOU M, J Hum Hypertens, 20 (2006) 225.
12. CHEUNG YF, Korean Circ J, 40 (2010) 153.
13. BOUTOUYRIE P, REVERA M, PARATI G, J Hypertens, 27 (2009) 2159.
14. REUSZ GS, CSEPREKAL O, TEMMAR M, KIS E, CHERIF AB, THALEB A, FEKETE A, SZABO AJ,BENETOS A, SALVI P, Hypertension, 56 (2010) 217.
15. CHAOSUWANNAKIT N, DAGOSTINO JR R, HAMILTON CA, LANE KS, NTIM WO, LAWRENCE J, MELIN SA, ELLIS LR, TORTI FM, LITTLE WC, HUNDLEY WG, J Clin Oncol, 28 (2010) 166.
16. TANIGUCHI I, Intern Med, 44 (2005) 89.
17. CHEITLIN MD, ALPERT JS, ARMSTRONG WF, AURIGEMMA GP, BELLER GA, BIERMAN FZ, DAVIDSON TW, DAVIS JL, DOUGLAS PS, GILLAM LD, Circulation, 95 (1997) 1686.
18. DE SIMONE G, DANIELS SR, DEVEREUX RB, MEYER RA, ROMAN MJ, DE DIVITIIS O, ALDERMAN MH, J Am Coll Cardiol, 20 (1992) 1251.
19. HORVATH IG, NEMETH A, LENKEY Z, ALESSANDRI N, TUFANO F, KIS P, GASZNER B, CZIRAKI A, J Hypertens, 28 (2010) 2068.
20. RAJZER MW, WOJCIECHOWSKA W, KLOCEK M, PALKA I, BRZOZOWSKA-KISZKA M, KAWECKA-JASZCZ K, J Hypertens, 26 (2008) 2001.
21. BAULMANN J, SCHILLINGS U, RICKERT S, UEN S, DUSING R, ILLYES M, CZIRAKI A, NICKERING G, MENGDEN T, J Hypertens, 26 (2008) 523.
22. JATOI NA, MAHMUD A, BENNETT K, FEELY J, J Hypertens, 27 (2009) 2186.
23. MULROONEY DA, YEAZEL MW, KAWASHIMA T, MERTENS AC, MITBY P, STOVALL M, DONALDSON SS, GREEN DM, SKLAR CA, ROBISON LL, LEISENRING WM, BMJ, 339 (2009) 339.
24. VINEREANU D, NICOLAIDES E, BODEN L, PAYNE N, JONES CJ, FRASER AG, Heart, 89 (2003) 449.
25. KIS E, CSEPREKAL O, HORVATH Z, KATONA G, FEKETE BC, HRAPKA E, SZABO A, SZABO AJ, FEKETE A, REUSZ GS, Pediatr Res, 63 (2008) 95.
26. MUKHOPADHYAY P, RAJESH M, BATKAI S, KASHIWAYA Y, HASKO G, LIAUDET L, SZABO C, PACHER P, Am J Physiol Heart Circ Physiol, 296 (2009) H1466.
27. HUDSON MM, RAI SN, NUNEZ C, MERCHANT TE, MARINA NM, ZALAMEA N, COX C, PHIPPS S, POMPEU R, ROSENTHAL D, J Clin Oncol, 25 (2007) 3635.
28. HERCEG ČAVRAK V, Evaluation of cytostatic late cardiac effects in pediatric patients. MS Thesis. In Croat (University of Zagreb, Zagreb, 2003).